FORMULATIONS OF RALTEGRAVIR
The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of raltegravir, an inert superdisintegrant, and a binder; and an extragranular component comprising a superdisintegrant and a lubricant.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
23.03.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of raltegravir, an inert superdisintegrant, and a binder; and an extragranular component comprising a superdisintegrant and a lubricant. |
|---|---|
| AbstractList | The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of raltegravir, an inert superdisintegrant, and a binder; and an extragranular component comprising a superdisintegrant and a lubricant. |
| Author | MAHJOUR, Majid SMITH, Ronald, L |
| Author_xml | – fullname: MAHJOUR, Majid – fullname: SMITH, Ronald, L |
| BookMark | eNrjYmDJy89L5WSQdvMP8g31cQzx9PcLVvB3Uwhy9AlxdQ9yDPMM4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BxhYGhqbGRo4mxkQoAQD6CyIV |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | PRÉPARATIONS DE RALTÉGRAVIR FORMULIERUNGEN VON RALTEGRAVIR |
| ExternalDocumentID | EP3801532A4 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP3801532A43 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 15:04:43 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP3801532A43 |
| Notes | Application Number: EP20190814132 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220323&DB=EPODOC&CC=EP&NR=3801532A4 |
| ParticipantIDs | epo_espacenet_EP3801532A4 |
| PublicationCentury | 2000 |
| PublicationDate | 20220323 |
| PublicationDateYYYYMMDD | 2022-03-23 |
| PublicationDate_xml | – month: 03 year: 2022 text: 20220323 day: 23 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | Merck Sharp & Dohme Corp |
| RelatedCompanies_xml | – name: Merck Sharp & Dohme Corp |
| Score | 3.3864074 |
| Snippet | The present invention is directed to compressed tablets for oral administration, which comprise an intragranular component comprising the potassium salt of... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | FORMULATIONS OF RALTEGRAVIR |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220323&DB=EPODOC&locale=&CC=EP&NR=3801532A4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LSsNAcKhV1JtWpbUqOUhuwbq7zeMQJM3DKk0TQlp6K3lsoJdabMTfd3ZNqxe9Dbswuzswr50XwD0ntEArVDS6tUyNlTzT8ky3NF4MKkZyk5UyYhpO9fGMvS6GixasdrUwsk_op2yOiBxVIL_XUl5vfj6xPJlbuX3IV7j09hSktqc23jER88Cp6o1sP468yFVdFyF1mtgUJfGQEocdwKGwokWbfX8-EkUpm98aJTiDoxiRretzaPF1B07c3eC1DhyHTbwbwYb1thfQR3ctnE2-y36VKFASZ5L6z4kzf0kuQQn81B1reMpy_6KlH-_vQ6-gjY4-74KSoXvBeJbx3EBWqnhGLKM0qF49FoybA9qD3p9orv_Z68OpII3InCL0Btr1-we_RVVa53eSCF9GWnTk |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsJAcIJoxJuiBsRHD6a3Rtxd-jgQU_qwaAukKYQb2bbbhAsSqfH3na2AXvQ22U1mdyeZ184L4F4QmqEVKhvdWqbGcsG1lOuWJrJuwUhqsryKmEYjPZiyl3lvXoPlrham6hP6WTVHRI7KkN_LSl6vfz6x3Cq3cvOQLnHp7clP-q669Y6JnAdOVXfQ9yZjd-yojoOQOor7FCVxjxKbHcChIZvzSstpNpBFKevfGsU_haMJIluVZ1ATqyY0nN3gtSYcR9t4N4Jb1tucQwfdtWgafpf9KmNfie0w8Z5jezaML0DxvcQJNDxlsX_Rwpvs70MvoY6OvmiBwtG9YIJzkRrISoXgxDJyg-rFY8aE2aVtaP-J5uqfvTtoBEkULsLh6LUDJ5JMMouK0Guol-8f4gbVapneVgT5AuWRd9E |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FORMULATIONS+OF+RALTEGRAVIR&rft.inventor=MAHJOUR%2C+Majid&rft.inventor=SMITH%2C+Ronald%2C+L&rft.date=2022-03-23&rft.externalDBID=A4&rft.externalDocID=EP3801532A4 |